Security
iHuman Inc. American depositary shares, each representing five Class A ordinary shares · IH
IHNYSEotherCurrentCIK 1814423Updated Oct 6, 2026
IH price & chart
Loading TradingView…
NYSE:IH on TradingView ↗About the company
iHuman Inc. is a leading provider of tech-powered knowledge and personal growth products. Backed by 30 years of experience serving children and families, iHuman combines cutting-edge technologies, a distinctive edutainment philosophy, and high-quality original content to help users expand their horizons, unlock their potential, and foster personal growth. The Company has built a comprehensive product ecosystem spanning interactive digital applications, smart devices, consumer products, and a popular, award-winning animation division. By integrating AI, machine learning, AR/VR, 3D engines, and big data analytics with meticulously crafted content, iHuman delivers engaging and highly personalized experiences for users of all ages, helping them acquire knowledge, develop skills, and enhance their overall capabilities. Through its rapidly expanding international presence, iHuman is cultivating a vibrant global user community and extending the reach of its products, content, and proprietary IPs to families and users around the world.
In the news
iHuman Inc. Files 2025 Annual Report on Form 20-F ↗
Recent filings
Show 5 more recent filings
Financials
FY 2025 · USDSource
Source
Source
Source
Source
Source
balance sheet · annual statements
| Line item | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|
| ASSETS | ||||
| AssetsUSD | 195,673,000Source | 194,490,000Source | 204,297,000Source | 193,326,000Source |
| Property, Plant and Equipment, NetUSD | 367,000Source | 476,000Source | 869,000Source | 1,335,000Source |
| Current assets: | ||||
| Cash and Cash Equivalents, at Carrying ValueUSD | 164,608,000Source | 153,890,000Source | 170,956,000Source | 152,236,000Source |
| Accounts Receivable, after Allowance for Credit Loss, CurrentUSD | 6,731,000Source | 7,128,000Source | 8,568,000Source | 11,543,000Source |
| Inventory, NetUSD | 3,058,000Source | 3,216,000Source | 2,327,000Source | 2,773,000Source |
| Assets, CurrentUSD | 185,665,000Source | 183,006,000Source | 194,713,000Source | 181,783,000Source |
| Prepaid Expense and Other Assets, CurrentUSD | 10,651,000Source | 12,263,000Source | 12,607,000Source | 14,900,000Source |
| Operating Lease, Right-of-Use AssetUSD | 1,657,000Source | 2,039,000Source | 514,000Source | 1,853,000Source |
| Other Assets, NoncurrentUSD | 1,696,000Source | 3,110,000Source | 1,218,000Source | 931,000Source |
| LIABILITIES AND EQUITY | ||||
| LiabilitiesUSD | 53,365,000Source | 62,856,000Source | 69,393,000Source | 81,766,000Source |
| Stockholders’ equity: | ||||
| Common Stock, Value, IssuedUSD | 27,000Source | 25,000Source | 26,000Source | 27,000Source |
| Additional Paid in CapitalUSD | 137,370,000Source | 136,541,000Source | 153,330,000Source | 156,455,000Source |
| Retained Earnings (Accumulated Deficit)USD | 7,612,000Source | -5,768,000Source | -19,784,000Source | -46,566,000Source |
| Accumulated Other Comprehensive Income (Loss), Net of TaxUSD | 2,307,000Source | 3,289,000Source | 2,529,000Source | 1,522,000Source |
| Stockholders' Equity Attributable to ParentUSD | 142,308,000Source | 131,634,000Source | 134,904,000Source | 111,560,000Source |
| Liabilities and EquityUSD | 195,673,000Source | 194,490,000Source | 204,297,000Source | 193,326,000Source |
| Current liabilities: | ||||
| Liabilities, CurrentUSD | 52,048,000Source | 61,314,000Source | 69,121,000Source | 81,346,000Source |
| Operating Lease, Liability, CurrentUSD | 310,000Source | 502,000Source | 271,000Source | 888,000Source |
| Accounts Payable, CurrentUSD | 3,587,000Source | 4,142,000Source | 3,118,000Source | 3,510,000Source |
| Operating Lease, Liability, NoncurrentUSD | 1,317,000Source | 1,542,000Source | 272,000Source | 420,000Source |
| Additional Financial Items | ||||
| Accrued Liabilities, CurrentUSD | 4,799,000Source | 4,145,000Source | 4,047,000Source | 3,530,000Source |
| Dividends Payable, CurrentUSD | — | 296,000Source | — | — |
| Short-term InvestmentsUSD | — | 6,228,000Source | — | — |
cash flow · annual statements
| Line item | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|
| Cash flows from operating activities: | ||||
| Adjustments to reconcile net income to net cash provided by operating activities: | ||||
| Depreciation, Depletion and AmortizationUSD | 1,108,000Source | 1,871,000Source | 1,647,000Source | 1,571,000Source |
| Share-based Payment Arrangement, Noncash ExpenseUSD | 103,000Source | 387,000Source | 1,329,000Source | 1,891,000Source |
| Changes in operating assets and liabilities: | ||||
| Increase (Decrease) in Accounts ReceivableUSD | -726,000Source | -1,264,000Source | -2,577,000Source | 4,133,000Source |
| Increase (Decrease) in InventoriesUSD | -65,000Source | 991,000Source | -427,000Source | -974,000Source |
| Net Cash Provided by (Used in) Operating ActivitiesUSD | 7,338,000Source | 8,021,000Source | 24,242,000Source | 27,324,000Source |
| Cash flows from investing activities: | ||||
| Net Cash Provided by (Used in) Investing ActivitiesUSD | 5,800,000Source | -7,228,000Source | -917,000Source | -4,762,000Source |
| Cash flows from financing activities: | ||||
| Payments for Repurchase of Common StockUSD | 2,458,000Source | 1,319,000Source | 1,344,000Source | 1,009,000Source |
| Net Cash Provided by (Used in) Financing ActivitiesUSD | -8,021,000Source | -14,013,000Source | -1,331,000Source | -1,009,000Source |
| Dividends paid | — | — | — | — |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate EffectUSD | 3,979,000Source | -12,395,000Source | 23,067,000Source | 28,220,000Source |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash EquivalentsUSD | 164,608,000Source | 153,890,000Source | 170,956,000Source | 152,236,000Source |
| Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash EquivalentsUSD | -1,138,000Source | 825,000Source | 1,073,000Source | 6,667,000Source |
| Additional Financial Items | ||||
| Share-based Payment Arrangement, ExpenseUSD | 103,000Source | 387,000Source | 1,329,000Source | 1,891,000Source |
| Amortization of Intangible AssetsUSD | 890,000Source | 1,396,000Source | 1,074,000Source | 972,000Source |
| DepreciationUSD | 218,000Source | 475,000Source | 573,000Source | 599,000Source |
| Dividends Payable, CurrentUSD | — | 296,000Source | — | — |
| Equity Securities without Readily Determinable Fair Value, Impairment Loss, Annual AmountCNY | 0Source | 0Source | 0Source | 0Source |
| General and Administrative ExpenseUSD | 13,076,000Source | 13,598,000Source | 14,695,000Source | 15,832,000Source |
| Income Tax Expense (Benefit)USD | 913,000Source | 1,646,000Source | 3,052,000Source | 3,328,000Source |
| Inventory Write-downUSD | 233,000Source | 38,000Source | -60,000Source | 320,000Source |
| Net Income (Loss) Attributable to ParentUSD | 13,643,000Source | 13,506,000Source | 25,479,000Source | 15,922,000Source |
| Net Income (Loss) Available to Common Stockholders, BasicUSD | — | — | — | 15,922,000Source |
| Operating ExpensesUSD | 68,761,000Source | 77,849,000Source | 79,070,000Source | 84,033,000Source |
| Other Nonoperating Income (Expense)USD | 5,010,000Source | 5,300,000Source | 6,012,000Source | 3,072,000Source |
| Proceeds from Stock Options ExercisedUSD | 26,000Source | 6,000Source | 13,000Source | 0Source |
income statement · annual statements
| Line item | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|
| Total RevenueUSD | 115,402,000Source | 126,341,000Source | 143,402,000Source | 142,887,000Source |
| Cost of Goods and Services Sold | — | — | — | — |
| Operating Income (Loss)USD | 9,546,000Source | 9,852,000Source | 22,519,000Source | 16,178,000Source |
| Other Nonoperating Income (Expense)USD | 5,010,000Source | 5,300,000Source | 6,012,000Source | 3,072,000Source |
| Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling InterestUSD | 14,556,000Source | 15,152,000Source | 28,531,000Source | 19,250,000Source |
| Income Tax Expense (Benefit)USD | 913,000Source | 1,646,000Source | 3,052,000Source | 3,328,000Source |
| Net Income (Loss) Attributable to ParentUSD | 13,643,000Source | 13,506,000Source | 25,479,000Source | 15,922,000Source |
| Earnings Per Share, BasicUSD per share | 0.05Source | 0.05Source | 0.1Source | 0.06Source |
| Earnings Per Share, DilutedUSD per share | 0.05Source | 0.05Source | 0.09Source | 0.06Source |
| Weighted Average Number of Shares Outstanding, Basicshares | 256,975,188Source | 262,001,916Source | 264,052,936Source | 266,535,220Source |
| Weighted Average Number of Shares Outstanding, Dilutedshares | 267,614,972Source | 271,198,755Source | 273,765,128Source | 270,204,542Source |
| Additional Financial Items | ||||
| Amortization of Intangible AssetsUSD | 890,000Source | 1,396,000Source | 1,074,000Source | 972,000Source |
| Current Income Tax Expense (Benefit)USD | 913,000Source | 1,646,000Source | 3,052,000Source | 3,328,000Source |
| Equity Securities without Readily Determinable Fair Value, Impairment Loss, Annual AmountCNY | 0Source | 0Source | 0Source | 0Source |
| General and Administrative ExpenseUSD | 13,076,000Source | 13,598,000Source | 14,695,000Source | 15,832,000Source |
| Gross ProfitUSD | 78,307,000Source | 87,701,000Source | 101,589,000Source | 100,211,000Source |
| Net Income (Loss) Available to Common Stockholders, BasicUSD | — | — | — | 15,922,000Source |
| Operating ExpensesUSD | 68,761,000Source | 77,849,000Source | 79,070,000Source | 84,033,000Source |
| Research and Development ExpenseUSD | 29,807,000Source | 33,943,000Source | 36,275,000Source | 45,450,000Source |
| Selling and Marketing ExpenseUSD | 25,878,000Source | 30,308,000Source | 28,100,000Source | 22,751,000Source |
Filing attachments
tm2626563d1_ex99-1.htm · 6-K · 2026-09-29
Exhibit 99.1 iHuman Inc. Announces Second Quarter 2026 Unaudited Financial Results BEIJING, China, Sep. 29, 2026 -- iHuman Inc. (NYSE: IH) (“iHuman” or the “Company”), a leading provider of tech-powered knowledge and personal growth products, today announced its unaudited financial results for the second quarter ended June 30, 2026. Second Quarter 2026 Highlights1 Revenues were RMB173.4 million (US$25.6 million), compared with RMB210.9 million in the same period last year. Gross p…
Read attachment ↗tm2619281d1_ex99-1.htm · 6-K · 2026-06-29
Exhibit 99.1 iHuman Inc. Announces First Quarter 2026 Unaudited Financial Results BEIJING, China, Jun. 29, 2026 -- iHuman Inc. (NYSE: IH) (“iHuman” or the “Company”), a leading provider of tech-powered knowledge and personal growth products, today announced its unaudited financial results for the first quarter ended March 31, 2026. First Quarter 2026 Highlights Revenues were RMB182.5 million (US$26.5 million), compared with RMB210.4 million in the same period last year. Gross profit wa…
Read attachment ↗tm2610721d1_ex99-1.htm · 6-K · 2026-03-31
Exhibit 99.1 iHuman Inc. Announces Fourth Quarter and Fiscal Year 2025 Unaudited Financial Results BEIJING, China, Mar. 31, 2026 -- iHuman Inc. (NYSE: IH) (“iHuman” or the “Company”), a leading provider of tech-powered, intellectual development products in China, today announced its unaudited financial results for the fourth quarter and fiscal year ended December 31, 2025. Fourth Quarter 2025 Highlights Revenues were RMB190.7 million (US$27.3 million), compared with RMB232.7 million in t…
Read attachment ↗